Volume 18, Number 2—February 2012
Dispatch
Multiorgan Dysfunction Caused by Travel-associated African Trypanosomiasis
Table 1
Treatment regimen for Trypanosoma brucei rhodesiense infection in adults*
| Disease stage | Drug, route of administration | Regimen | Adverse effects |
|---|---|---|---|
| First | Suramin, intravenous | Test dose of 100 mg in 100 mL 0.9% saline over 30 min on day 0; and 5 doses of 20 mg/kg (maximum 1 g/dose) in 250 mL 0.9% saline over 3 h on days 1, 3, 7, 14, 21 | Hypersensitivity reactions (early and late); nephrotoxicity, hepatotoxicity, hemolytic anemia, peripheral neuropathy, agranulocytosis, thrombocytopenia, and cutaneous reactions |
| Second | Melarsoprol, intravenous | 2.0–3.6 mg/kg/d (maximum 180 mg/d) for 3 d; after 7 d, 3.6 mg/kg/d for 3 d; after 7 more d, 3.6 mg/kg/d for 3 d† | Encephalopathy, cutaneous reactions, peripheral neuropathy, cardiac arrhythmias, thrombophlebitis, fever, and gastric upset |
1Current affiliation: Worthing Hospital, Worthing, UK.


